Severely immunocompromised HIV-infected paediatric patient with drug-resistant cytomegalovirus infection treated with subcutaneous interleukin-2.
Pere
P
Soler-Palacín
Susana
S
Clemente
Andrea
A
Martín
Maria Josep
MJ
Cabañas
Eduard
E
Hidalgo
Concepció
C
Figueras
D017088:AIDS-Related Opportunistic Infections / Q000821:virology; D000293:Adolescent; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D018791:CD4 Lymphocyte Count; D019559:Capillary Leak Syndrome / Q000139:chemically induced; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy*; D024921:Drug Resistance, Multiple, Viral; D017809:Fatal Outcome; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000821:virology*; D019247:HIV Wasting Syndrome / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D008297:Male; D019562:Viral Load
D018712:Analgesics, Non-Narcotic; D007376:Interleukin-2